CASP8 and renal carcinoma: Patients with renal cancer recurrence exhibited higher levels of CASP8 mRNA when compared to patients who did not recur, and increased expression levels of CASP8 were associated with worse disease-free survival in renal cancer patients (Fig. 4A, p = 0.0071).